<?xml version="1.0" encoding="UTF-8"?>
<ref id="ddr21709-bib-0093">
 <mixed-citation publication-type="journal" id="ddr21709-cit-0093">
  <string-name>
   <surname>Kim</surname>, 
   <given-names>U. J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Won</surname>, 
   <given-names>E. J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Kee</surname>, 
   <given-names>S. J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Jung</surname>, 
   <given-names>S. I.</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>Jang</surname>, 
   <given-names>H. C.</given-names>
  </string-name> (
  <year>2016</year>). 
  <article-title>Combination therapy with lopinavir/ritonavir, ribavirin and interferon‐α for Middle East respiratory syndrome</article-title>. 
  <source xml:lang="en">Antiviral Therapy</source>, 
  <volume>21</volume>(
  <issue>5</issue>), 
  <fpage>455</fpage>–
  <lpage>459</lpage>. 
  <pub-id pub-id-type="doi">10.3851/imp3002</pub-id>
  <pub-id pub-id-type="pmid">26492219</pub-id>
 </mixed-citation>
</ref>
